|
CCDC97 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.728800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.569200E-01 |
| Normal-vs-Stage2 |
8.028200E-01 |
| Normal-vs-Stage3 |
3.027000E-01 |
| Normal-vs-Stage4 |
8.602600E-01 |
| Stage1-vs-Stage2 |
9.905400E-01 |
| Stage1-vs-Stage3 |
1.415180E-01 |
| Stage1-vs-Stage4 |
9.851000E-01 |
| Stage2-vs-Stage3 |
3.251000E-01 |
| Stage2-vs-Stage4 |
9.809000E-01 |
| Stage3-vs-Stage4 |
4.536400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.116000E-01 |
| Normal-vs-AfricanAmerican |
8.744400E-01 |
| Normal-vs-Asian |
7.580000E-01 |
| Caucasian-vs-AfricanAmerican |
9.392200E-01 |
| Caucasian-vs-Asian |
6.984800E-01 |
| AfricanAmerican-vs-Asian |
7.144600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.821200E-01 |
| Normal-vs-Female |
7.097800E-02 |
| Male-vs-Female |
2.516000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.630800E-01 |
| Normal-vs-Extreme_Weight |
4.672800E-01 |
| Normal-vs-Obese |
1.557760E-01 |
| Normal-vs-Extreme_Obese |
2.893000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.953000E-01 |
| Normal_Weight-vs-Obese |
1.974840E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.309600E-01 |
| Extreme_Weight-vs-Obese |
4.287700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.026000E-01 |
| Obese-vs-Extreme_Obese |
1.367980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.372300E-02 |
| Normal-vs-Age(41-60Yrs) |
6.421500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.072800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.978980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.495240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.642060E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.509610E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.100770E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.054000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.273200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.143400E-01 |
| Normal-VS-Type2 PRCC |
3.761800E-01 |
| Normal-VS-KIRP CIMP |
9.559200E-01 |
| Normal-VS-Unclassified PRCC |
1.779400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.459900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.093200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.837400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.553000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.566100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.111200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.980800E-01 |
| Normal-vs-N1 |
9.731700E-02 |
| Normal-vs-N2 |
6.192600E-01 |
| N0-vs-N1 |
5.349700E-02 |
| N0-vs-N2 |
2.722600E-01 |
| N1-vs-N2 |
2.338600E-01 |
|
|
